Roche

News

Roche bolsters diagnostics with $295m LumiraDx deal

A flurry of mergers and acquisitions in the pharma space at the end of 2023 ended with a $295 million deal by Roche to buy a point-of-care diagnostics platform from Lumira

News

Genentech confirms Magargee as permanent CEO

Roche’s Genentech unit has looked internally for its new chief executive, appointing Ashley Magargee to the role following the departure of Alexander Hardy last month.

News

Merck pummelled as MS hope evobrutinib dies in phase 3

Germany’s Merck KGaA is facing a big hole in its late-stage pipeline after multiple sclerosis (MS) candidate evobrutinib missed the mark in two phase 3 trials, spelling th

News

Roche bounces back in PIK3 with inavolisib data

A few years ago, Roche abandoned the development of its lead PIK3CA-targeting drug taselisib on safety grounds, allowing rival Novartis to beat it to market, but now it ha

News

Roche makes obesity play with $2.7bn deal to buy Carmot

Roche has agreed a deal to acquire US biotech Carmot Therapeutics that, if consummated, will thrust it into the increasingly competitive market for incretin-based therapie

News

Genentech, NVIDIA partner on ‘lab-in-a-loop’ AI platform

NVIDIA’s push into the life sciences sector has been rewarded by a wide-ranging deal with Roche’s Genentech subsidiary aimed at accelerating the use of generative artificial intellige

Roche bolsters diagnostics with $295m LumiraDx deal

Genentech confirms Magargee as permanent CEO

Merck pummelled as MS hope evobrutinib dies in phase 3

Roche bounces back in PIK3 with inavolisib data

Roche makes obesity play with $2.7bn deal to buy Carmot

Genentech, NVIDIA partner on ‘lab-in-a-loop’ AI platform

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Roche

Editor's Picks